Avoro Capital Advisors LLC
Filing Date
Global Rank
#412
/ 8,603
▲ 78
· as of Mar 2026
Top Industry
Biotechnology
82.4%
3Y Alpha vs SPY
+3.9%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+97.1%
SPY
+76.5%
Annualised alpha
+4.5%
Max drawdown
−30.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
30 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
17.2%
+3.7 pts
Top 5
51.6%
−2.1 pts
Top 10
77.1%
−1.2 pts
HHI
785
Diversified+15
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $10,399,603,451 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc | +1,537,223 | 12,315,000 | $104,308,050 | |
| TERN | Terns Pharmaceuticals, Inc. | +1,345,000 | 5,695,000 | $300,240,400 | |
| CELC | Celcuity Inc. | +463,889 | 3,575,000 | $408,050,500 | |
| XENE | Xenon Pharmaceuticals Inc. | +353,333 | 5,777,777 | $335,977,732 | |
| RVMD | Revolution Medicines, Inc. | +174,444 | 2,344,444 | $227,997,179 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +74,999 | 10,699,999 | $670,889,937 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +10,681 | 1,818,181 | $951,763,208 | |
| ARGX | Argenx SE | +10,000 | 1,000,000 | $730,250,000 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | −3,125,100 | 11,430,455 | $454,017,672 | |
| MNKD | Mannkind Corp | −2,244,444 | 2,200,000 | $5,390,000 | |
| LXEO | Lexeo Therapeutics, Inc. | −1,425,000 | 1,875,000 | $10,762,500 | |
| SLNO | Soleno Therapeutics Inc | −600,000 | 2,300,000 | $77,004,000 | |
| ALKS | Alkermes plc. | −200,000 | 1,200,000 | $42,432,000 | |
| QURE | uniQure N.V. | −190,405 | 5,959,595 | $97,439,378 | |
| ASND | Ascendis Pharma A/S | −98,611 | 5,062,500 | $1,157,945,625 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 3,010,000 | $1,784,869,800 | |
| CYTK | Cytokinetics Inc | 3,333,333 | $219,699,978 | |
| DMRA | Damora Therapeutics, Inc. | 3,783,000 | $97,979,700 | |
| DFTX | Definium Therapeutics, Inc. | 5,000,000 | $94,500,000 | |
| AVTX | Avalo Therapeutics, Inc. | 1,410,000 | $21,051,300 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
30 positions ·
$10,399,603,451 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 3,010,000 | $1,784,869,800 | 17.16% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 5,062,500 | $1,157,945,625 | 11.13% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 1,818,181 | $951,763,208 | 9.15% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Held | 2,888,888 | $746,257,548 | 7.18% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 1,000,000 | $730,250,000 | 7.02% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 10,699,999 | $670,889,937 | 6.45% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 7,474,747 | $622,571,677 | 5.99% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Held | 12,222,222 | $491,699,991 | 4.73% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 11,430,455 | $454,017,672 | 4.37% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 3,575,000 | $408,050,500 | 3.92% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 5,777,777 | $335,977,732 | 3.23% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Held | 6,555,555 | $315,977,751 | 3.04% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 5,695,000 | $300,240,400 | 2.89% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 5,888,888 | $236,909,964 | 2.28% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 2,344,444 | $227,997,179 | 2.19% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 3,333,333 | $219,699,978 | 2.11% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 12,315,000 | $104,308,050 | 1.00% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 3,783,000 | $97,979,700 | 0.94% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 5,959,595 | $97,439,378 | 0.94% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 21,700,000 | $96,999,000 | 0.93% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 5,000,000 | $94,500,000 | 0.91% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 2,300,000 | $77,004,000 | 0.74% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 1,200,000 | $42,432,000 | 0.41% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 1,337,500 | $32,140,125 | 0.31% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 1,500,000 | $29,340,000 | 0.28% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 1,800,000 | $25,308,000 | 0.24% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 1,410,000 | $21,051,300 | 0.20% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Reduced | 1,875,000 | $10,762,500 | 0.10% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 2,849,402 | $9,830,436 | 0.09% | |
| MNKD |
Mannkind Corp
Healthcare
|
Reduced | 2,200,000 | $5,390,000 | 0.05% |